Farmas USA

Modo movil

http://www.investornewswire.com/analyst-views/earnings-surprise-in-focus-threshold-pharmaceuticals-inc-nasdaqthld/14574/

Report FINANCIERO de THLD?
Experado -0,17$
Reportado -0.05$?

Por que no me ha llegado la press release a mi buzon de correo?? Que raro ...

NVAX. 10,17 en pre con algo de volumen, parece que va bien encauzada.

NVAX

Muy sinceramente creo que este valor ya está en propulsión... No creo que explosivo, hasta que no haya news, pero sí constante... Muy ilusionado con unas acciones que creo serán unas nuevas ADXS...

SNTA

Synta Announces Journal Publication Describing Complementary Activity of Hsp90 Inhibition and Immune Checkpoint Blockade for Cancer Therapy

The review article describes preclinical findings that suggest that proteasomal degradation of cellular client proteins associated with Hsp90 inhibition may augment antitumor immune response through increased cellular antigen expression and subsequent enhanced T-cell recruitment and tumor-cell recognition. The review article also explains that client proteins affected by Hsp90 inhibition include oncogenes that may drive expression of Programmed Death-Ligand 1 (PD-L1), a key immune checkpoint. The resulting reduction of PD-L1 expression on tumor cells may increase T-cell mediated cytotoxic activity and complement the activity of selective anti-PD-1 or anti-PD-L1 antibody therapies.

http://finance.yahoo.com/news/synta-announces-journal-publication-describing-120000851.html

NVAX

De Zacks:

investors are probably asking themselves, can this positive trend continue for NVAX?

While we can never know for sure, it is pretty encouraging that estimates for NVAX have moved higher in the past few weeks, meaning that analyst sentiment is moving in the right way.

http://finance.yahoo.com/news/uptrend-continue-novavax-nvax-tale-115611759.html

No se que es eso que he posteado antes porque ni en la web de THLD aparece nada de report financiero ni gaitas
http://investor.thresholdpharm.com/releases.cfm

Editado, no va aquí.

THLD

Nada, mirando por encima habla del Q1 finalizado el 31 de marzo, y luego dice: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) is next scheduled to report quarterly earnings on 2015-08-07. Así que resultados de Q2 según estos tipos está programado para el 7 de agosto.

Es más bien como un resumen de lo sucedido en Q1 y la media de precios objetivos, y demás cosas sin interés real.